From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
April 28, 2017
Philadelphia, PA, April 28, 2017 – IntegriChain, a leading healthcare technology company delivering enriched data and analytics for distribution, patient access, and market access, today announced that registration is now open for its 2017 User Conference to be held October 23 to 25 in Nashville, TN. This year’s conference features a strong Executive Summit program, offering deep insights from business cases and benchmarking studies on patient and market access challenges. Additionally, the 2017 User Conference will feature manufacturer best-practice case studies as well as new industry topic tracks and hands-on training sessions. The agenda and registration are available on the IntegriChain User Conference registration site.
“We continue to evolve our User Conference program to improve the quality and deliverables of the multi-day event, expanding the breadth of the agenda to cover the issues bio/pharma managed market and national account teams face today and the ones that will challenge them tomorrow,” said Josh Halpern, IntegriChain Co-Founder and EVP. “We’ll focus on how to drive value from channel, specialty, and payer data to improve patient experience optimization and market access in the specialty era. We are looking forward to seeing all of our customers in Nashville for an outstanding conference.”
This year’s IntegriChain User Conference is designed to deliver value and insights that attendees can return to their bio/pharmaceutical organizations:
About IntegriChain IntegriChain is a rapidly growing healthcare technology company, offering the leading cloud for enriched data and analytics to optimize distribution, patient access, and market access for life sciences managed markets teams. Pharmaceutical, biopharm/specialty pharma, generics, and medtech suppliers leverage insights from IntegriChain’s unmatched factory-to-patient visibility to maximize patient access and to address critical risks throughout the patient access and product life cycle. IntegriChain delivers the enriched data and analytics foundation for more efficient and service-oriented channel models for mature product categories as well as for innovative products that must balance significant therapeutic benefit with out-of-pocket costs and benefit hurdles. Today IntegriChain is the trusted partner for all top-10 bio/pharmaceutical companies, 17 of the top-20 life science companies, and more than 50 other suppliers, totaling more than $250 billion in annual US commerce. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. For more information, visit www.integrichain.com and our blog, and follow us on Twitter @IntegriChain and LinkedIn.
IntegriChain is a registered trademark of IntegriChain Incorporated. All other trademarks are property of their respective owners.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com
Save the date!
Webinars & Resources
See List